HIV 1 News and Research

RSS

PhoreMost announces two key appointments to strengthen leadership team

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has made two appointments to strengthen its leadership team, as the Company positions itself for growth.

From PhoreMost 3 Feb 2020

Investigational HIV vaccine not effective in preventing HIV

The National Institute of Allergy and Infectious Diseases), part of the National Institutes of Health, has stopped administration of vaccinations in its HVTN 702 clinical trial of an investigational HIV vaccine.

3 Feb 2020

HIV antibody therapy improves immune function

A new study published in the journal Nature Medicine in February 2020 reports that the administration of neutralizing antibodies against HIV improve the recipient’s specific T cell responses against the virus.

3 Feb 2020

Coronavirus taking an economic toll on China

The novel coronavirus or 2019-nCoV outbreak has negatively impacted the economy of China and other countries worldwide. With China’s isolation from other countries and travel bans imposed, the economic toll is rippling across the world.

3 Feb 2020

New, highly potent HIV antibody restricts development of viral resistance

Antiretroviral drugs are the gold standard for the treatment of HIV infection. They are highly effective in suppressing replication of the virus but require lifelong daily application and can be associated with side effects.

31 Jan 2020

A collaborative partnership to understand the impact of music therapies on mental health

The Health and Technology District has partnered with Music Heals and SFU on a new research study using advanced neuroscience and functional brain imaging to understand the neuro-physiological impacts of music therapies on improved mental health.

31 Jan 2020

Warren is right. Presidents have the power to bypass Congress on drug pricing

On the presidential primary campaign trail in Iowa, Sen. Elizabeth Warren (D-Mass.) brought out a favorite talking point: ways the president can bring down drug prices without waiting for Congress.

31 Jan 2020

5 things to know about Trump’s Medicaid block grant plan

The Trump administration unveiled a plan Thursday that would dramatically revamp Medicaid by allowing states to opt out of part of the current federal funding program and instead seek a fixed payment each year in exchange for gaining unprecedented flexibility over the program.

31 Jan 2020

State-purchased insurance plans improve HIV outcomes, save healthcare costs

Health insurance purchased by state AIDS Drug Assistance Programs for people living with HIV in states that did not expand Medicaid are improving outcomes and have the potential to save millions in healthcare costs, a new study suggests.

30 Jan 2020

Research uncovers how HIV develops resistance to key drugs

The mechanism behind how HIV can develop resistance to a widely-prescribed group of drugs has been uncovered by new research from the Crick and Dana-Farber Cancer Institute, with the findings opening the door to the development of more effective treatments.

30 Jan 2020

Trump’s latest health care challenge: Gaining voters’ trust

Far more Americans disapprove of President Donald Trump's handling of several high-profile health care issues than give him positive marks, underscoring the challenge the president faces in claiming health care as a political asset in his reelection bid.

30 Jan 2020

Global funding for neglected disease research reaches a record high

For the first time, global funding for neglected disease R&D grew for three consecutive years, reaching a record high of more than US$4.05 billion in 2018.

30 Jan 2020

New treatment target could change the outlook of patients at risk of kidney injury

Kidney injury is a dreaded complication of commonly performed procedures such as coronary angiography or cardiac surgery, often stopping physicians and patients in their tracks.

30 Jan 2020

Travel data reveals top 20 cities at risk of Wuhan coronavirus spread

The Wuhan coronavirus or 2019-N-CoV has spread across the globe, including Australia, United States, Cambodia, Canada, France, Germany, Japan, Malaysia, Nepal, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, and Vietnam.

28 Jan 2020

New experimental model developed for 'lipid rafts' in living cells

It is a rather trivial statement: if you want to enter the house through a door, it is best to take a key in your hand, open and go inside. But if you have no idea what the key looks like or where it is hidden - under the doormat, on the basement stairs? - it becomes much more difficult.

27 Jan 2020

Study examines brain link to STI/HIV sexual risk

Data show that young adult women in the United States have high rates of sexually transmitted infections (STIs) that increase their risk of HIV. Though epidemiologic and behavioral factors for risk have been studied, we know very little about brain factors that may be linked to STI/ HIV sexual risk.

27 Jan 2020

Coronavirus could turn into a new pandemic

With news that the coronavirus called 2019-nCoV is capable of spreading from human to human, many are concerned about the possibility of a new pandemic, and that is not outside the realm of possibility, according to Jeff Hogan, a professor and infectious disease expert at the University of Georgia, who studied the SARS coronavirus extensively.

24 Jan 2020

New Distinguished Scholar Award aims to mitigate gender gaps in medical research

The Icahn School of Medicine at Mount Sinai-;an international leader in medical and scientific training, biomedical research, and patient care-;today announced the recipients of the first-of-its-kind Distinguished Scholar Award, a new annual grant sponsored by the Office of Gender Equity in Science and Medicine. The awards aim to mitigate gender gaps in medical research by supporting researchers with additional project resources while they serve as family caretakers.

23 Jan 2020

New study gives hope for potentially developing a cure for HIV

HIV latency is considered one of the biggest challenges to developing a cure for the virus.

23 Jan 2020

Controlled-release opioids may lead to endocarditis in injection drug users

A new study from ICES, Lawson Health Research Institute and Western University suggests that injection drug users prescribed controlled-release hydromorphone are three times more likely to develop endocarditis, a serious bacterial heart infection, when compared to those prescribed other opioids.

22 Jan 2020